ODYY
Odyssey Health, Inc.Company Information
- Company Name
- Odyssey Health, Inc.
- CIK
- CIK0001626644
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- ODYY: OTC
- Fiscal Year End
- July 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- ODYY
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2024-06-30
- Institutional shares owned
- 1,000,000
- Shares outstanding
- 97,064,040
- Ownership
- 1.03%
Earnings Market Reaction
- Filing date
- 2026-06-12
- Price on filing date
- —
- 1-month reaction
- -14.29%
- 3-month reaction
- 28.57%
Balance Sheet
Values in millions ($)| Line item | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 | 2023-07-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Receivables Net Current | - | - | - | - | 0 | 0 | 0 | 0 | - | - | - | 0 | ||||||
| Other Receivables Gross Current | - | - | - | 0 | - | - | - | 0 | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | ||||||
| Investments | - | - | - | 0 | 0 | 0 | 0 | 1 | 13 | 14 | - | 0 | ||||||
| Finite Lived Intangible Assets Net | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 14 | 14 | 1 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | ||||||
| Accrued Salaries Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | ||||||
| Interest Payable Current | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Sold Under Agreements To Repurchase Repurchase Liability | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Convertible Notes Payable Current | - | - | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Notes And Loans Payable Current | 3 | 2 | - | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | ||||||
| Other Notes Payable Current | - | 0 | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Derivative Liabilities Current | 2 | 4 | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Convertible Debt Current | - | 2 | 1 | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities Current | 10 | 11 | 7 | 7 | 7 | 7 | 7 | 6 | 6 | 5 | 7 | 7 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 56 | 56 | 56 | 56 | 56 | 56 | 56 | 56 | 56 | 56 | 54 | 54 | ||||||
| Retained Earnings Accumulated Deficit | -66 | -67 | -63 | -63 | -62 | -62 | -62 | -61 | -48 | -47 | -61 | -60 | ||||||
| Stockholders Equity | -10 | -11 | -7 | -7 | 7 | -6 | -6 | -5 | 8 | 9 | -6 | -6 | ||||||
| Liabilities And Stockholders Equity | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 14 | 14 | 1 | 0 | ||||||
| Finite Lived Intangible Assets Accumulated Amortization | - | - | - | - | - | - | - | - | 0 | 0 | 0 | - | ||||||
| Debt Instrument Unamortized Discount Current | - | 3 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 500 | 500 | 500 | 500 | - | 500 | 500 | 500 | 500 | 500 | 500 | 500 | ||||||
| Common Stock Shares Issued | 101 | 100 | 100 | 97 | 97 | 97 | 97 | 97 | 96 | 94 | 82 | 79 | ||||||
| Shares Outstanding | 101 | 100 | 100 | 97 | 97 | 97 | 97 | 97 | 96 | 94 | 82 | 79 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialOdyssey Health, Inc. (ODYY) — SEC Financial Statements & Analysis
Odyssey Health, Inc. (ODYY) is a surgical & medical instruments & apparatus company, incorporated in NV. Odyssey Health, Inc. trades on OTC as: ODYY. Odyssey Health, Inc. (ODYY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-04-30, filed with the SEC on 2026-06-12. Based on that filing, Odyssey Health, Inc. carries a market cap of $6.16M, a P/E ratio of -1.72x, a P/B ratio of -0.63x, an enterprise value of $5.86M, and an EV/EBITDA multiple of -6.24x. On profitability, it posts a Return on Equity (ROE) of 234.41%, a Return on Assets (ROA) of -1326.84%, and a Return on Invested Capital (ROIC) of -15.54%. Per share, it reports EPS of $-0.03, diluted EPS of $-0.02, free cash flow per share of $-0.01, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -74.90% year-over-year and EPS growth of -75.68% year-over-year. On the balance sheet, it maintains a current ratio of 0.04x, a quick ratio of 0.03x, working capital of $-9.75M, a debt-to-equity ratio of -1.04x, a debt ratio of 27.08, an interest coverage ratio of -0.86x, free cash flow of $-934.98K (TTM), and net debt of $-297.81K. Figures sourced from SEC EDGAR.
- Market Cap
- $6.16M
- P/E TTM
- -1.72x
- EPS TTM
- $-0.03
- P/B TTM
- -0.63x
- ROE TTM
- 234.41%
- ROA TTM
- -1326.84%
- Debt To Equity
- -1.04x
- Free Cash Flow TTM
- $-934.98K
Data as of 2026-04-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Odyssey Health, Inc. in?
Odyssey Health, Inc. (ODYY) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does ODYY trade on?
Odyssey Health, Inc. (ODYY) trades on the OTC.
Where is Odyssey Health, Inc. incorporated?
Odyssey Health, Inc. is incorporated in NV.
When was Odyssey Health, Inc. (ODYY)'s most recent SEC filing?
Odyssey Health, Inc. (ODYY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-04-30, filed with the SEC on 2026-06-12.
What is ODYY's market cap?
Odyssey Health, Inc. (ODYY) has a market capitalization of $6.16M as of 2026-04-30.
What is ODYY's EPS (earnings per share)?
Odyssey Health, Inc. (ODYY)'s trailing twelve month EPS is $-0.03 as of 2026-04-30.
What is ODYY's ROE (return on equity)?
Odyssey Health, Inc. (ODYY)'s trailing twelve month Return on Equity (ROE) is 234.41% as of 2026-04-30.
What is ODYY's ROA (return on assets)?
Odyssey Health, Inc. (ODYY)'s trailing twelve month Return on Assets (ROA) is -1326.84% as of 2026-04-30.
What is ODYY's ROIC (return on invested capital)?
Odyssey Health, Inc. (ODYY)'s trailing twelve month Return on Invested Capital (ROIC) is -15.54% as of 2025-04-30.
What is ODYY's EV/EBITDA?
Odyssey Health, Inc. (ODYY)'s trailing twelve month EV/EBITDA is -6.24x as of 2026-04-30.